1.Combination treatment in the management of type 2 diabetes: focus on vildagliptin and metformin as a single tablet

作　　者：Serge Halimi ;Anja Schweizer ;Biljana Minic 等

出　　处：Vascular Health and Risk Management. 2008 ;4(3):481-492.doi:10.2147/VHRM.S2503

出版社：Dove Medical Press Ltd

文章 ID：91373385

文章详细全文下载
2.Assessing the general safety and tolerability of vildagliptin: value of pooled analyses from a large safety database versus evaluation of individual studies

作　　者：Anja Schweizer ;Sylvie Dejager ;James E Foley 等

出　　处：Vascular Health and Risk Management. 2011 ;7:49-57.doi:10.2147/VHRM.S16925

出版社：Dove Medical Press Ltd

文章 ID：91373777

文章详细全文下载
3.Evidence to support the use of vildagliptin monotherapy in the treatment of type 2 diabetes mellitus

作　　者：Sylvie Dejager ;Anja Schweizer ;James E Foley

出　　处：Vascular Health and Risk Management. 2012 ;8:339-348.doi:10.2147/VHRM.S31758

出版社：Dove Medical Press Ltd

文章 ID：91373819

文章详细全文下载
4.Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

作　　者：Anja Schweizer ;James E Foley ;Wolfgang Kothny 等

出　　处：Vascular Health and Risk Management. 2013 ;9:57-64.doi:10.2147/VHRM.S40972

出版社：Dove Medical Press Ltd

文章 ID：91373923

文章详细全文下载
5.Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment

作　　者：Valentina Lukashevich ;Anja Schweizer ;James E Foley 等

出　　处：Vascular Health and Risk Management. 2013 ;9:21-28.doi:10.2147/VHRM.S39300

出版社：Dove Medical Press Ltd

文章 ID：91373927

文章详细全文下载
6.A double-blind, randomized trial, including frequent patient–physician contacts and Ramadan-focused advice, assessing vildagliptin and gliclazide in patients with type 2 diabetes fasting during Ramadan: the STEADFAST study

作　　者：Mohamed Hassanein ;Khalifa Abdallah ;Anja Schweizer

出　　处：Vascular Health and Risk Management. 2014 ;10:319-326.doi:10.2147/VHRM.S64038

出版社：Dove Medical Press Ltd

文章 ID：91373940

文章详细全文下载
7.Changes in body weight after 24 weeks of vildagliptin therapy as a function of fasting glucose levels in patients with type 2 diabetes

作　　者：Matthias Blüher ;Anja Schweizer ;Giovanni Bader 等

出　　处：Vascular Health and Risk Management. 2014 ;10:661-664.doi:10.2147/VHRM.S73608

出版社：Dove Medical Press Ltd

文章 ID：95543447

文章详细全文下载
8.Blood pressure and fasting lipid changes after 24 weeks’ treatment with vildagliptin: a pooled analysis in >2,000 previously drug-naïve patients with type 2 diabetes mellitus

作　　者：Marc Evans ;Anja Schweizer ;James E Foley

出　　处：Vascular Health and Risk Management. 2016 ;12:337-340.doi:10.2147/VHRM.S112148

出版社：Dove Medical Press Ltd

文章 ID：199279147

文章详细全文下载

	Bo Ahrén	1篇
	Giovanni Bader	1篇
	James Foley	1篇
	Khalifa Abdallah	1篇
	Marc Evans	1篇
	Matthias Blüher	1篇
	Mohamed Hassanein	1篇
	Per-Henrik Groop	1篇
	Serge Halimi	1篇
	Sheila Dickinson	1篇
	Valentina Lukashevich	1篇

全文

出版年度

作者

文章类型

来源期刊

学科主题

语种

国别/地区

检索条件:"( ( 高级检索(( ((AU:(("Anja Schweizer")))) )) ) )"

	Anja Schweizer	8篇
	James E Foley	6篇
	Sylvie Dejager	3篇
	Wolfgang Kothny	3篇
	Biljana Minic	1篇

	2016	1篇
	2014	2篇
	2013	2篇
	2012	1篇
	2011	1篇